Tuesday 28 April 2009

Meticel Ofteno




Meticel Ofteno may be available in the countries listed below.


Ingredient matches for Meticel Ofteno



Hypromellose

Hypromellose is reported as an ingredient of Meticel Ofteno in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Mexico

  • Nicaragua

  • Panama

International Drug Name Search

Monday 27 April 2009

Amemodium




Amemodium may be available in the countries listed below.


Ingredient matches for Amemodium



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Amemodium in the following countries:


  • Vietnam

International Drug Name Search

Amoxicilina Cuve




Amoxicilina Cuve may be available in the countries listed below.


Ingredient matches for Amoxicilina Cuve



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Cuve in the following countries:


  • Spain

International Drug Name Search

Wednesday 22 April 2009

Depant Prolong




Depant Prolong may be available in the countries listed below.


Ingredient matches for Depant Prolong



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Depant Prolong in the following countries:


  • Slovakia

International Drug Name Search

Diclofenac Actavis




Diclofenac Actavis may be available in the countries listed below.


Ingredient matches for Diclofenac Actavis



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Actavis in the following countries:


  • Germany

International Drug Name Search

Saturday 18 April 2009

Atelvia


Atelvia is a brand name of risedronate, approved by the FDA in the following formulation(s):


ATELVIA (risedronate sodium - tablet, delayed release; oral)



  • Manufacturer: WARNER CHILCOTT

    Approval date: October 8, 2010

    Strength(s): 35MG [RLD]

Has a generic version of Atelvia been approved?


No. There is currently no therapeutically equivalent version of Atelvia available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atelvia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pharmaceutical compositions containing geminal diphosphonates
    Patent 5,583,122
    Issued: December 10, 1996
    Inventor(s): Benedict; James J. & Perkins; Christopher M.
    Assignee(s): The Procter & Gamble Company
    Pharmaceutical compositions, useful for treating abnormal calcium and phosphate metabolism, which contain geminal-diphosphonic acid compounds; and a method of treating diseases characterized by abnormal calcium and phosphate metabolism utilizing these pharmaceutical compositions.
    Patent expiration dates:

    • December 10, 2013
      ✓ 
      Patent use: TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
      ✓ 
      Drug substance
      ✓ 
      Drug product


    • June 10, 2014
      ✓ 
      Pediatric exclusivity




  • Dosage forms of risedronate
    Patent 5,622,721
    Issued: April 22, 1997
    Inventor(s): Dansereau; Richard J. & Mosher; Russell Y. & Axelrod; Douglas W. & Sietsema; William K.
    Assignee(s): The Procter & Gamble Company
    The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical composition which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower gastrointestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which occasionally accompanies the oral administration of risedronate active ingredients.
    Patent expiration dates:

    • April 21, 2014
      ✓ 
      Patent use: TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
      ✓ 
      Drug product




  • Dosage forms of bisphosphonates
    Patent 7,645,459
    Issued: January 12, 2010
    Inventor(s): Dansereau; Richard John & Burgio, Jr.; David Ernest
    Assignee(s): The Procter & Gamble Company
    Oral dosage forms of a bisphosphonate comprised of a safe and effective amount of a pharmaceutical composition comprising a bisphosphonate, a chelating agent, and, means for effecting delayed release of the bisphosphonate and the chelating agent in the lower gastrointestinal tract provide delivery of the pharmaceutical composition to the lower gastrointestinal tract of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between bisphosphonates and food or beverages, which interaction results in the bisphosphonate active ingredient not being available for absorption. The resulting oral dosage form may thus be taken with or without food. Further, the present invention effects delivery of the bisphosphonate and the chelating agent to the lower GI tract, substantially alleviating the upper GI irritation associated with bisphosphonate therapies. These benefits simplify previously complex treatment regimens and can lead to increased patient compliance with bisphosphonate therapies.
    Patent expiration dates:

    • January 9, 2028
      ✓ 
      Patent use: TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
      ✓ 
      Drug product




  • Dosage forms of risedronate
    Patent 7,645,460
    Issued: January 12, 2010
    Inventor(s): Dansereau; Richard John & Burgio, Jr.; David Ernest
    Assignee(s): The Procter & Gamble Company
    Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between risedronate and food or beverages, which interaction results in the bisphosphonate active ingredient not being available for absorption. The resulting oral dosage form may thus be taken with or without food. Further, the present invention effects delivery of risedronate and the chelating agent to the small intestine, substantially alleviating the upper GI irritation associated with bisphosphonate therapies. These benefits simplify previously complex treatment regimens and can lead to increased patient compliance with bisphosphonate therapies.
    Patent expiration dates:

    • January 9, 2028
      ✓ 
      Patent use: TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 8, 2013 - NEW DOSAGE FORM

See also...

  • Atelvia Consumer Information (Drugs.com)
  • Atelvia Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Atelvia Consumer Information (Cerner Multum)
  • Atelvia Advanced Consumer Information (Micromedex)
  • Risedronate Delayed-Release Tablets Consumer Information (Wolters Kluwer)
  • Risedronate Tablets Consumer Information (Wolters Kluwer)
  • Risedronate Consumer Information (Cerner Multum)
  • Risedronate Advanced Consumer Information (Micromedex)
  • Risedronate Sodium AHFS DI Monographs (ASHP)

Postinor




Postinor may be available in the countries listed below.


Ingredient matches for Postinor



Levonorgestrel

Levonorgestrel is reported as an ingredient of Postinor in the following countries:


  • Argentina

  • Australia

  • Austria

  • Belgium

  • Czech Republic

  • Egypt

  • Estonia

  • Georgia

  • Iceland

  • Latvia

  • Luxembourg

  • New Zealand

  • Norway

  • Portugal

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovakia

  • Spain

  • Sweden

  • Syria

  • Venezuela

  • Yemen

International Drug Name Search

Friday 17 April 2009

Orajel Mouth-Aid


Generic Name: benzocaine topical (BENZ oh kane TOP ik al)

Brand Names: Americaine, Americaine Hemorrhoidal, Anacaine, Anbesol Gel, Anbesol Liquid, Babee Teething Lotion, Benzo-O-Stetic, Boil Ease Pain Relieving, Cepacol Extra Strength, Cepacol Fizzlers, Dent-O-Kain, Dermoplast, Detane, Hurricaine, Lanacane, Maintain, Medicone Maximum Strength, Num-Zit, Numzident, Orabase, Orabase Gel-B, Orajel, Orajel Denture, Oral Pain Relief, OraMagic Plus, Outgro Pain Relief, Retre-Gel, Rid-A-Pain, Skeeter Stik, Solarcaine Aerosol, Sting-Kill, Topex, Trocaine, Vagisil Feminine Cream, zilactin-B


What is Orajel Mouth-Aid (benzocaine topical)?

Benzocaine is a local anesthetic (numbing medication). It works by blocking nerve signals in your body.


Benzocaine topical is used to reduce pain or discomfort caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, ingrown toenails, hemorrhoids, and many other sources of minor pain on a surface of the body. Benzocaine is also used to numb the skin or surfaces inside the mouth, nose, throat, vagina, or rectum to lessen the pain of inserting a medical instrument such as a tube or speculum.


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Orajel Mouth-Aid (benzocaine topical)?


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms of methemoglobinemia may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE ANY OF THESE SYMPTOMS: headache, tired feeling, confusion, fast heart rate, and feeling light-headed or short of breath, with a pale, blue, or gray appearance of your skin, lips, or fingernails.


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. Do not use this medicine on a child younger than 2 years old without medical advice. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Use the smallest amount of this medication needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Before using benzocaine topical, tell your doctor if you have any type of inherited enzyme deficiency, heart disease, a breathing disorder such as asthma, bronchitis, or emphysema, or if you smoke.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


What should I discuss with my health care provider before using Orajel Mouth-Aid (benzocaine topical)?


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • asthma, bronchitis, emphysema, or other breathing disorder;




  • heart disease;




  • a personal or family history of methemoglobinemia, or any genetic (inherited) enzyme deficiency; or




  • if you smoke.




FDA pregnancy category C. It is not known whether benzocaine topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.. It is not known whether benzocaine topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medicine on a child younger than 2 years old without medical advice.

How should I use Orajel Mouth-Aid (benzocaine topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Use the smallest amount of medicine needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


This medication comes with instructions for safe and effective application. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


To treat minor skin conditions, apply a thin layer of benzocaine topical to the affected area up to 4 times per day. If using the spray, hold the container 6 to 12 inches away from the skin. Do not spray this medication onto your face. Spray it instead on your hands and then rub it onto the face, avoiding contact with your eyes.


To treat hemorrhoids, clean the area with soap and water before applying benzocaine topical. Apply the medication up to 6 times per day. If you are using the rectal suppository, try to empty your bowel and bladder before inserting the suppository. Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Do not use benzocaine topical to treat large skin areas or deep puncture wounds. Avoid using the medicine on skin that is raw or blistered, such as a severe burn or abrasion.

Call your doctor if your symptoms do not improve or if they get worse within the first 7 days of using benzocaine topical. Also call your doctor if your symptoms had cleared up but then came back.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since benzocaine topical is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of benzocaine topical applied to the skin can cause life-threatening side effects such as uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

What should I avoid while taking Orajel Mouth-Aid (benzocaine topical)?


Avoid eating within 1 hour after using benzocaine topical on your gums or inside your mouth.


Benzocaine topical is for use only on the surface of your body, or just inside the mouth, vagina, or rectum. Avoid getting this medication in your eyes. Avoid swallowing the gel, liquid, or ointment while applying it to your gums or the inside of your mouth. The throat spray or oral lozenge may be swallowed gradually during use.

Do not apply other medications to the same affected areas you treat with benzocaine topical, unless your doctor has told you otherwise.


Orajel Mouth-Aid (benzocaine topical) side effects


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE:



  • headache, tired feeling, confusion;




  • fast heart rate;




  • feeling light-headed or short of breath; and




  • pale, blue, or gray appearance of your skin, lips, or fingernails.




Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzocaine topical and call your doctor at once if you have any of these other serious side effects:

  • headache, weakness, dizziness, breathing problems, fast heart rate, and gray or bluish colored skin (rare but serious side effects of benzocaine);




  • severe burning, stinging, or sensitivity where the medicine is applied;




  • swelling, warmth, or redness; or




  • oozing, blistering, or any signs of infection.



Less serious side effects may include:



  • mild stinging, burning, or itching where the medicine is applied;




  • skin tenderness or redness; or




  • dry white flakes where the medicine was applied.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Orajel Mouth-Aid (benzocaine topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied benzocaine topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Orajel Mouth-Aid resources


  • Orajel Mouth-Aid Side Effects (in more detail)
  • Orajel Mouth-Aid Use in Pregnancy & Breastfeeding
  • Orajel Mouth-Aid Support Group
  • 0 Reviews for Orajel Mouth-Aid - Add your own review/rating


  • Americaine Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Anacaine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Anbesol Extra Strength Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benz-O-Sthetic Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lanacane Aerosol Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • OraMagic Plus Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rid-A-Pain Topical Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Orajel Mouth-Aid with other medications


  • Aphthous Ulcer
  • Oral and Dental Conditions


Where can I get more information?


  • Your pharmacist can provide more information about benzocaine topical.

See also: Orajel Mouth-Aid side effects (in more detail)


Thursday 16 April 2009

Cefixime Ogb Dexa




Cefixime Ogb Dexa may be available in the countries listed below.


Ingredient matches for Cefixime Ogb Dexa



Cefixime

Cefixime is reported as an ingredient of Cefixime Ogb Dexa in the following countries:


  • Indonesia

International Drug Name Search

Saturday 11 April 2009

Aciclovir Aristo




Aciclovir Aristo may be available in the countries listed below.


Ingredient matches for Aciclovir Aristo



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Aristo in the following countries:


  • Germany

International Drug Name Search

Friday 10 April 2009

Bacter-NZ




Bacter-NZ may be available in the countries listed below.


Ingredient matches for Bacter-NZ



Nitazoxanide

Nitazoxanide is reported as an ingredient of Bacter-NZ in the following countries:


  • India

Ofloxacin

Ofloxacin is reported as an ingredient of Bacter-NZ in the following countries:


  • India

International Drug Name Search

Wednesday 8 April 2009

Lactatrim




Lactatrim may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Lactatrim



Sulfadiazine

Sulfadiazine is reported as an ingredient of Lactatrim in the following countries:


  • Ireland

Trimethoprim

Trimethoprim is reported as an ingredient of Lactatrim in the following countries:


  • Ireland

International Drug Name Search

Monday 6 April 2009

Pravastatine Winthrop




Pravastatine Winthrop may be available in the countries listed below.


Ingredient matches for Pravastatine Winthrop



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatine Winthrop in the following countries:


  • France

International Drug Name Search

Rumetrace Magnesium




Rumetrace Magnesium may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Rumetrace Magnesium



Magnesium

Magnesium is reported as an ingredient of Rumetrace Magnesium in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Saturday 4 April 2009

Anyfen




Anyfen may be available in the countries listed below.


Ingredient matches for Anyfen



Dexibuprofen

Dexibuprofen is reported as an ingredient of Anyfen in the following countries:


  • Vietnam

International Drug Name Search